Get started
Live feed
·
SECFilingvia Quantisnow
bioAffinity Technologies Inc. logo

BIAF: SEC Form 8-K filed by bioAffinity Technologies Inc.

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Full content unavailable. See the original source below.

Historical context for BIAF

Across the 23 sessions after earlier BIAF headlines, the stock closed higher 12 times and lower 11 times, with a median move of 8.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

BIAF close-to-close change in the session after earlier headlines
SessionEarlier headlineBIAFSPY
Oct 29, 2026bioAffinity Technologies Highlights Importance of Link Between Early Lung Cancer Detection and Curative Treatment During National Lung Cancer Awareness Month-3.5%-0.4%
Oct 15, 2026bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026+11.2%+0.3%
Oct 9, 2026WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rulesand 1 other headline that session-16.2%+0.6%
Oct 8, 2026WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rulesand 2 other headlines that session-8.4%-0.4%
Oct 6, 2026bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026-2.1%+0.5%
Sep 30, 2026bioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL-4.7%-0.2%
Quantisnow market dataNASDAQ
bioAffinity Technologies Inc. logo
BIAF
bioAffinity Technologies Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Commercial Physical & Biological Resarch
Listed since
2022
Get push alerts for BIAF

Follow BIAF and get a push notification the moment its next story breaks.

Full BIAF profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIAF (bioAffinity Technologies Inc.) and more on Quantisnow.